Screening Technology Company Nuevolution Raises $13.7M | GenomeWeb

NEW YORK (GenomeWeb News) – Danish small-molecule lead discovery firm Nuevolution today announced it has raised DKK 80.5 million ($13.7 million).

Proceeds will go toward expansion of Nuevolution's operations directed at identifying small molecule lead compounds against "therapeutically important high value targets," it said. Industrifonden led the financing round. Other participants include Sunstone Capital, SEB Venture Capital, and SEB Utvecklingsstiftelse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.